Ambiq Micro Inc is a fabless semiconductor company that has developed technology based on a patented Sub-threshold Power Optimized Technology (SPOT) platform that significantly reduces the amount of power consumed by integrated circuits... Show more
Ambiq Micro, Inc. (NYSE: AMBQ) is an Austin, Texas-based fabless semiconductor company that designs ultra-low-power microcontrollers (MCUs) and systems-on-chip (SoCs). Its patented Subthreshold Power Optimized Technology (SPOT) platform and HELIA AI ecosystem are engineered to extend battery life in always-on, battery-operated devices. The company's Apollo SoC family and newer Atomiq edge-AI products serve applications including smartwatches, hearables, smart rings, AR/VR glasses, medical monitors, smart-home devices, and industrial IoT sensors, with more than 300 million devices shipped worldwide.
Founded in 2010 and publicly listed on the NYSE since July 2025, Ambiq has positioned itself at the intersection of ultra-low-power silicon and edge artificial intelligence. Investors follow the stock for its exposure to the fast-growing edge-AI theme, while weighing its still-negative earnings and reliance on a concentrated set of large customers and a single foundry partner.
Over the past 30 days, AMBQ has declined about 23%, moving from a close of $58.56 on October 9 to roughly $44.93 in early November. The move has been volatile rather than linear: after peaking near $73 in late September, the stock grinded lower through October and accelerated into early November, closing at $35.22 on November 5 before rebounding.
The longer view tells a similar story. Across the trailing three months, the stock is down approximately 30% from mid-August levels in the mid-$60s. From its late-September high near $73 to the November 5 close of $35.22, shares dropped roughly 52% at the trough before recovering. Despite this correction, AMBQ remains well above its 52-week low and is still up strongly for 2026, reflecting the extent of its earlier rally.
Several factors converged to pressure the stock. First, valuation. After a rapid run-up tied to edge-AI enthusiasm, the shares traded at levels that independent fair-value analysis flagged as stretched, setting the stage for a de-rating once momentum faded.
Second, insider selling. Between September and October, several executives, including the chief financial officer, chief technology officer, chief executive officer, and chief operating officer, disclosed stock sales collectively exceeding $2.6 million. While at least one transaction was described as tax-related to restricted-stock vesting, the cluster of filings was read by the market as a signal that insiders saw limited near-term upside.
Third, analyst actions cut both ways. Jefferies initiated coverage with a Buy rating and a $90 target in early October, and Stifel raised its target to $85. But in early November, UBS cut its price target to $50 from $73 while keeping a Neutral rating, reinforcing the cautious tone. Persistent GAAP losses and negative operating cash flow also kept a lid on sentiment as the market rotated away from higher-valuation, pre-profit semiconductor names.
The quarterly trend reflects a broader unwinding of an exceptionally strong run. Ambiq's fiscal second-quarter report in mid-August delivered a large earnings beat—revenue of $33.9 million, up roughly 90% year over year, against a loss of $0.07 per share versus a $0.26 loss consensus—and management raised its full-year sales outlook to about $135 million. That news powered a rally into late September.
As the quarter progressed, however, the stock gave back those gains. Slower sequential growth implied by third-quarter guidance, industry-wide supply-chain tightness, continued cash burn, and a wave of insider sales combined with a cautious sell-side revision to undermine the premium multiple the stock had carried. The result was a multi-week slide that erased most of the post-earnings advance and pushed shares toward the lower end of their recent trading range.
Tickeron's Trending AI Robots page curates a selection of the platform's AI-powered trading bots. Tickeron operates hundreds of algorithmic trading bots that monitor thousands of tickers, but only the top-performing and most relevant strategies are featured in this section. These bots vary in trading style, holding period, and performance metrics, giving traders a way to compare different automated approaches in one place. For investors seeking a data-driven perspective on names like AMBQ, reviewing the Trending AI Robots page can offer additional context on how automated systems are interpreting current market conditions.
The most immediate catalyst is Ambiq's third-quarter fiscal 2026 earnings report on November 10, 2026. Investors will scrutinize whether the company's roughly 90% year-over-year revenue growth is sustained, whether it meets the $36 million to $37 million sales guidance, and whether losses narrow as newer Apollo and Atomiq products ramp. Commentary on edge-AI demand across wearables and medical devices, supply-chain constraints, and the timeline to profitability will be closely watched.
Beyond earnings, key factors include the pace of customer adoption of the Apollo5 and Atomiq product lines, the company's cash-burn trajectory, customer and foundry concentration, and competitive pressure from larger semiconductor vendors expanding into low-power edge AI. Macroeconomic conditions affecting semiconductor demand and risk appetite for pre-profit growth stocks will also play a role in the stock's near-term direction.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The RSI Indicator for AMBQ moved out of oversold territory on November 09, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 2 similar instances when the indicator left oversold territory. In 2 of the 2 cases the stock moved higher. This puts the odds of a move higher at 90%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 10 of 14 cases where AMBQ's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 71%.
Following a +29.95% 3-day Advance, the price is estimated to grow further. Considering data from situations where AMBQ advanced for three days, in 52 of 70 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.
AMBQ may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on October 30, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AMBQ as a result. In 18 of 19 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
The Moving Average Convergence Divergence Histogram (MACD) for AMBQ turned negative on November 02, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 8 similar instances when the indicator turned negative. In 8 of the 8 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
AMBQ moved below its 50-day moving average on October 07, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for AMBQ crossed bearishly below the 50-day moving average on October 13, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 2 of 2 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AMBQ declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.
The Aroon Indicator for AMBQ entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 10 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 30 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.304) is normal, around the industry mean (5.443). P/E Ratio (-8.688) is within average values for comparable stocks, (15.640). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.803). Dividend Yield (0.000) settles around the average of (0.014) among similar stocks. P/S Ratio (14.771) is also within normal values, averaging (46.468).
The Tickeron Price Growth Rating for this company is 63 (best 1 - 100 worst), indicating steady price growth. AMBQ’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AMBQ’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry Semiconductors